Review
Published on 06 Oct 2022
Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
in Gastrointestinal and Hepatic Pharmacology
- 7,135 views
- 12 citations
Review
Published on 06 Oct 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 05 Oct 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 05 Oct 2022
in Gastrointestinal and Hepatic Pharmacology
Systematic Review
Published on 05 Oct 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 04 Oct 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 30 Sep 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 28 Sep 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 28 Sep 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 27 Sep 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 27 Sep 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 27 Sep 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 26 Sep 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 26 Sep 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 26 Sep 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 23 Sep 2022
in Gastrointestinal and Hepatic Pharmacology
Original Research
Published on 23 Sep 2022
in Gastrointestinal and Hepatic Pharmacology